MENU
+Compare
KZIA
Stock ticker: NASDAQ
AS OF
Nov 24, 04:58 PM (EDT)
Price
$8.57
Change
+$0.22 (+2.63%)
Capitalization
14.32M

KZIA Kazia Therapeutics Limited Forecast, Technical & Fundamental Analysis

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs... Show more

Industry: #Biotechnology
KZIA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for KZIA with price predictions
Nov 21, 2025

KZIA's Stochastic Oscillator reaching overbought zone

The Stochastic Oscillator for KZIA moved into overbought territory on November 21, 2025. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day moving average for KZIA crossed bearishly below the 50-day moving average on November 17, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KZIA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where KZIA's RSI Oscillator exited the oversold zone, of 45 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on November 21, 2025. You may want to consider a long position or call options on KZIA as a result. In of 77 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for KZIA just turned positive on November 21, 2025. Looking at past instances where KZIA's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

KZIA moved above its 50-day moving average on November 19, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where KZIA advanced for three days, in of 241 cases, the price rose further within the following month. The odds of a continued upward trend are .

KZIA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 85 cases where KZIA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. KZIA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.474) is normal, around the industry mean (27.249). P/E Ratio (0.000) is within average values for comparable stocks, (51.596). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.881). Dividend Yield (0.000) settles around the average of (0.047) among similar stocks. P/S Ratio (344.828) is also within normal values, averaging (320.418).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KZIA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
KZIA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a company, which engages in the business of pharmaceutical research and development

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
300 Barangaroo Avenue
Phone
+61 294724101
Employees
16
Web
https://www.kaziatherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IVA4.300.42
+10.82%
Inventiva SA
SLSN2.210.15
+7.28%
Solesence Inc
CUK24.121.06
+4.60%
Carnival PLC
GTIM1.260.01
+0.80%
Good Times Restaurants
GLNG36.09-0.27
-0.74%
Golar Lng Ltd

KZIA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, KZIA has been loosely correlated with SGMO. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if KZIA jumps, then SGMO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KZIA
1D Price
Change %
KZIA100%
+11.63%
SGMO - KZIA
37%
Loosely correlated
+9.97%
CLNN - KZIA
33%
Poorly correlated
+5.82%
LGVN - KZIA
30%
Poorly correlated
-0.56%
RVMD - KZIA
29%
Poorly correlated
+1.42%
TECX - KZIA
29%
Poorly correlated
+6.20%
More